CEBP:XETRA:XETRA-iShares VII PLC - iShares MSCI EMU USD Hedged ETF Acc (EUR)

ETF | Others |

Last Closing

USD 10.288

Change

-0.03 (-0.33)%

Market Cap

USD 0.20B

Volume

2.07K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-13 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.05 (-0.09%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.02 (-0.14%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.03 (-0.11%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.03 (-0.09%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.03 (-0.10%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

+0.21 (+0.46%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

-0.48 (-0.35%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.02 (-0.04%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.13 (-0.12%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-0.32 (-0.05%)

USD 80.38B

ETFs Containing CEBP:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.41% 91% A- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.41% 91% A- 87% B+
Trailing 12 Months  
Capital Gain 22.07% 78% C+ 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.07% 77% C+ 77% C+
Trailing 5 Years  
Capital Gain 67.28% 84% B 83% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 67.28% 82% B 80% B-
Average Annual (5 Year Horizon)  
Capital Gain 15.84% 85% B 82% B
Dividend Return 15.84% 84% B 81% B-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.19% 57% F 66% D+
Risk Adjusted Return 141.55% 100% F 100% F
Market Capitalization 0.20B 45% F 40% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Low market capitalization

This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.